Cite
Osteosarcoma-targeted Cu and Ce based oxide nanoplatform for NIR II fluorescence/magnetic resonance dual-mode imaging and ros cascade amplification along with immunotherapy.
MLA
Cheng, Mo, et al. “Osteosarcoma-Targeted Cu and Ce Based Oxide Nanoplatform for NIR II Fluorescence/Magnetic Resonance Dual-Mode Imaging and Ros Cascade Amplification along with Immunotherapy.” Journal of Nanobiotechnology, vol. 22, no. 1, Apr. 2024, pp. 1–16. EBSCOhost, https://doi.org/10.1186/s12951-024-02400-z.
APA
Cheng, M., Kong, Q., Tian, Q., Cai, W., Wang, C., Yuan, M., Wang, W., Wang, P., & Yan, W. (2024). Osteosarcoma-targeted Cu and Ce based oxide nanoplatform for NIR II fluorescence/magnetic resonance dual-mode imaging and ros cascade amplification along with immunotherapy. Journal of Nanobiotechnology, 22(1), 1–16. https://doi.org/10.1186/s12951-024-02400-z
Chicago
Cheng, Mo, Qingjie Kong, Qing Tian, Weiluo Cai, Chunmeng Wang, Minjia Yuan, Wenxing Wang, Peiyuan Wang, and Wangjun Yan. 2024. “Osteosarcoma-Targeted Cu and Ce Based Oxide Nanoplatform for NIR II Fluorescence/Magnetic Resonance Dual-Mode Imaging and Ros Cascade Amplification along with Immunotherapy.” Journal of Nanobiotechnology 22 (1): 1–16. doi:10.1186/s12951-024-02400-z.